Peptidomimetic star polymers for targeting biological ion channels

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Chen, Rong ^a   Lu, Derong ^b   Xie, Zili ^c   Feng, Jing ^c   Jia, Zhongfan ^b   Ho, Junming ^d   Coote, Michelle L ^d   Wu, Yingliang ^c   Monteiro, Michael J ^b   Chung, Shin Ho ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WUHAN UNIVERSITY   (China)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE GLYCOL DERIVATIVE; LYSINE; PEPTIDOMIMETIC AGENT; PEPTIDOMIMETIC STAR POLYMER; POLYMER; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV1.3; SCORPION VENOM; TRIPEPTIDE; UNCLASSIFIED DRUG; CHARYBDOTOXIN; ION CHANNEL;

ARTICLE; DISSOCIATION CONSTANT; DRUG DESIGN; DRUG SYNTHESIS; ION CURRENT; MAMMAL; MOLECULAR DYNAMICS; PROTEIN TARGETING; SIMULATION; DRUG EFFECTS; ELECTROPHYSIOLOGY; HEK293 CELL LINE; HUMAN; STRUCTURE ACTIVITY RELATION;

CHARYBDOTOXIN; ELECTROPHYSIOLOGY; HEK293 CELLS; HUMANS; ION CHANNELS; KV1.3 POTASSIUM CHANNEL; PEPTIDOMIMETICS; POLYMERS; POTASSIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84962069666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152169     Document Type: Article

References (33)

1. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discov Today. 2010;15:40-56 doi: 10.1016/j.drudis.2009.10.009 PMID: 19879957
2. Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, et al. Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem. 2003;278:46590-5 PMID: 12972419
3. Jiang YH, Emau P, Cairns JS, Flanary L, Morton WR, McCarthy TD, et al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses. 2005;21:207-13 PMID: 15795526
4. Bourne N, Stanberry LR, Kern ER, Holan G, Matthews B, Bernstein DI. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother. 2000;44:2471-4 PMID: 10952597
5. Liu TY, Hussein WM, Jia ZF, Ziora ZM, McMillan NAJ, Monteiro MJ, et al. Self-adjuvanting polymerpeptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules. 2013;14:2798-806 doi: 10.1021/bm400626w PMID: 23837675
6. Skwarczynski M, Zaman M, Urbani CN, Lin IC, Jia Z, Batzloff MR, et al. Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew Chem Int Ed. 2010;49:5742-5
7. Kaczorowski GJ, McManus OB, Priest BT, Garcia ML. Ion channels as drug targets: The next GPCRs. J Gen Physiol. 2008;131:399-405 doi: 10.1085/jgp. 200709946 PMID: 18411331
8. Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52:557-94 PMID: 11121510
9. England S, de Groot MJ. Subtype-selective targeting of voltage-gated sodium channels. Br J Pharmacol. 2009;158:1413-25 doi: 10.1111/j.1476-5381.2009.00437.x PMID: 19845672
10. McGivern JG. Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat. 2007;3:69-85 PMID: 19300539
11. Chi V, Pennington MW, Norton RS, Tarcha EJ, Londono LM, Sims-Fahey B, et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon. 2012;59:529-46 doi: 10.1016/j.toxicon. 2011.07.016 PMID: 21867724
12. Marr AK, Gooderham WJ, Hancock REW. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol. 2006;6:468-72 PMID: 16890021
13. + conduction and selectivity. Science. 1998;280:69-77 PMID: 9525859
14. + channel. Science. 2005;309:897-903 PMID: 16002581
15. Payandeh J, Scheuer T, Zheng N, Catterall WA. The crystal structure of a voltage-gated sodium channel. Nature. 2011;475:353-8 doi: 10.1038/nature10238 PMID: 21743477
16. Bontems F, Roumestand C, Gilquin B, Menez A, Toma F. Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins. Science. 1991;254:1521-3 PMID: 1720574
17. Gordon D, Chen R, Chung SH. Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications. Physiol Rev. 2013;93:767-802 doi: 10.1152/physrev. 00035.2012 PMID: 23589832
18. + channel. elife. 2013;2:e00594 doi: 10.7554/eLife.00594 PMID: 23705070
19. + channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111:1703-13 PMID: 12782673
20. Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A. 2006;103:17414-9 PMID: 17088564
21. Chen R, Robinson A, Gordon D, Chung SH. Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3). Biophys J. 2011;101:2652-60 doi: 10.1016/j.bpj.2011.10.029 PMID: 22261053
22. Chen R, Chung SH. Structural basis of the selective block of Kv1.2 by maurotoxin from computer simulations. PLoS One. 2012;7:e47253 doi: 10.1371/journal.pone.0047253 PMID: 23071772
23. Kumar S, Bouzida D, Swendsen RH, Kollman PA, Rosenberg JM. The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J Comput Chem. 1992;13:1011-21
24. Grossfield A. "WHAM: the weighted histogram analysis method", version 2.0.9 http://membrane.urmc.rochester.edu/content/wham2013 [7 March 2016].
25. Hub JS, de Groot BL, van der Spoel D. g-wham-A free weighted histogram analysis implementation including robust error and autocorrelation estimates. J Chem Theory Comput. 2010;6:3713-20
26. Lu D, Hossain MD, J Z., Monteiro MJ. One-pot orthogonal copper-catalyzed synthesis and self-assembly of L-lysine-decorated polymeric dendrimers. Macromolecules. 2015;48:1688-702
27. + channel in a lipid membrane-like environment. Nature. 2007;450:376-82 PMID: 18004376
28. + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 1994;45:1227-34 PMID: 7517498
29. Dennis A, Wang L, Wan X, Ficker E. hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem Soc Trans. 2007;35:1060-3 PMID: 17956279
30. Zaydman MA, Silva JR, Cui J. Ion channel associated diseases: overview of molecular mechanisms. Chem Rev. 2012;112:6319-33 doi: 10.1021/cr300360k PMID: 23151230
31. Bagal S, Brown AD, Cox PJ, Omoto K, Owen RM, Pryde DC, et al. Ion channels as therapeutic targets: A drug discovery perspective. J Med Chem. 2013;56:593-624 doi: 10.1021/jm3011433 PMID: 23121096
32. Klint JK, Smith JJ, Vetter I, Rupasinghe DB, Er SY, Senff S, et al. Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol. 2015;172:2445-58 doi: 10.1111/bph.13081 PMID: 25754331
33. Minett MS, Nassar MA, Clark AK, Passmore G, Dickenson AH, Wang F, et al. Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun. 2012;3:791 doi: 10.1038/ncomms1795 PMID: 22531176